Endonovo Therapeutics Awarded Preliminary Injunction

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Endonovo Therapeutics Awarded Preliminary Injunction Against Kodiak Capital et al

LOS ANGELES, CA--(Marketwired - Jun 23, 2016) - Endonovo Therapeutics, Inc. ( OTCQB : ENDV ) ("Endonovo" or the "Company"), a developer of bioelectronic medicine and therapies, announced it has been awarded a preliminary injunction by the Superior Court of California, County of Los Angeles, against Kodiak Capital, BMA Securities and COR Clearing, preventing the aforementioned parties from selling, transferring, hypothecating or otherwise touching or disposing of unpaid for shares tendered under the Equity Purchase Agreement (the "EPA") with Kodiak Capital. The preliminary injunction affirms a previously granted temporary restraining order placed on over 1.89 million shares of freely traded shares of common stock.

"We now have a preliminary injunction preventing the possible use of these unpaid for shares manipulating the market for our common stock," stated Endonovo Chairman and CEO, Alan Collier. "We intend to continue pursuing our rights through this lawsuit to protect our shareholders' value. We have brought this lawsuit to seek the cancellation or return of these unpaid shares to the Company and for other damages. We believe that success in these efforts will increase the likelihood of securing a larger round of financing and ensure a transparent market for our common stock thus preserving shareholder value."

Mr. Collier went on to say, "The Company intends to learn if these unpaid shares were utilized to manipulate the market price of our stock. Further, we plan to judiciously pursue our legal remedies to ensure our shareholders do not incur any damages and our stock price returns to appropriate levels."

About Endonovo Therapeutics

Endonovo Therapeutics, Inc. is an innovative biotechnology company developing bioelectronic devices and therapies for regenerative medicine. Endonovo's Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation, cell death and the promotion of regeneration. Endonovo's Cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies. The Company's initial concentration is on the treatment of acute and chronic inflammatory conditions of the liver using its proprietary Immunotronics™ platform.

Safe Harbor Statement

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Investors: Sign Up for Email Alerts on Endonovo 

Investor Relations Contact: Endonovo Therapeutics, Inc. Mr. Steven Barnes Vice President of Investor Relations (800) 701-1223, Ext. 108 Sbarnes@endonovo.com www.endonovo.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 0

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 55

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 275

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 71

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 407

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Balavant Insurance Group Welcomes John Jankowski as CIO

Updated Category News Views 317

Leadership Appointment at Balavant Insurance Group Balavant Insurance Group has made a significant move by appointing John Jankowski as its new Chief Information Officer. This announcement marks a pivotal moment for the company, known for its focus on technological advancement and innovative insurance solutions. Strategic Role of the Chief Information Officer In his role,...

Continue Reading
Exploring the Growth of the Industrial Absorbent Sector

Updated Category News Views 245

Understanding the Industrial Absorbent Market Dynamics The industrial absorbent market is poised for remarkable growth, expected to reach $5.50 billion by 2031. This growth trajectory aligns with a compound annual growth rate (CAGR) of 4.3%. The increase in market size is largely driven by the rising usage of absorbents across various industries in response to...

Continue Reading
ChoiceOne Financial Services Achieves Successful Bank Merger

Updated Category News Views 147

Successful Bank Merger by ChoiceOne Financial Services ChoiceOne Financial Services, Inc. (NASDAQ: COFS), the parent company of ChoiceOne Bank, has achieved a significant milestone by completing the consolidation of The State Bank into ChoiceOne Bank. This strategic move empowers the strength of ChoiceOne, further enhancing its service capabilities and market presence. A...

Continue Reading
Danantara Indonesia and INA Forge Nickel Investment Alliance with Eramet

Updated Category News Views 443

Strategic Collaboration for Nickel Development In a significant move to bolster the nickel downstream industry, partners including Danantara Indonesia and the Indonesia Investment Authority (INA) have officially signed a Memorandum of Understanding (MoU) with the prominent French mining company, Eramet. This collaboration aims to create an extensive investment platform...

Continue Reading
Full Moon Bar-B-Que's Generous Initiative for Local Kids

Updated Category News Views 180

Full Moon Bar-B-Que's Generosity In a heartwarming gesture, Full Moon Bar-B-Que has made a significant impact on the community by contributing $200,000 worth of backpacks and school supplies. Their ongoing commitment through the Backpack Blessings program is not just about donations; it's about nurturing and empowering local children who need support the most. Supporting...

Continue Reading